SCHEMBL4091564

SCHEMBL4091564

O=C(O)c1ccccc1C(=O)O[C@@H](CCCl)c1cccs1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.42
ALOX15 P16050 2/20 0.41
LMNA P02545 2/20 0.41
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
UTS2R Q9UKP6 2/20 0.36
SLC6A2 P23975 3/20 0.33
SLC6A4 P31645 3/20 0.33
SLC6A3 Q01959 2/20 0.33
TP53 P04637 1/20 0.33
POLB P06746 1/20 0.33
THRB P10828 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
KDM4E B2RXH2 1/20 0.33
TAAR1 Q96RJ0 1/20 0.33
CES2 O00748 1/20 0.33
CES1 P23141 1/20 0.33
KEAP1 Q14145 1/20 0.33
NPC1 O15118 1/20 0.32
RAB9A P51151 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4087510 1.00 ALDH1A1 (0.42) ALDH1A1ALOX15LMNAMEN1KMT2A
SCHEMBL8448930 0.85 HPGD (0.43) ALDH1A1LMNAMEN1KMT2AUTS2R
SCHEMBL21401236 0.82 SLC6A2 (0.46) ALDH1A1ALOX15LMNAMEN1KMT2A
SCHEMBL4087799 0.81 ALDH1A1 (0.48) ALDH1A1ALOX15LMNAUTS2RKDM4E
SCHEMBL4078629 0.81 ALDH1A1 (0.48) ALDH1A1ALOX15LMNAUTS2RKDM4E
SCHEMBL13900893 0.76 NPC1 (0.38) ALDH1A1LMNAMEN1KMT2ASLC6A2
SCHEMBL21102465 0.74 SLC6A4 (0.46) ALDH1A1ALOX15MEN1KMT2ASLC6A2
SCHEMBL20917118 0.71 CACNA2D1 (0.48) KMT2ASLC6A2NPC1RAB9A
SCHEMBL30438633 0.71 CACNA2D1 (0.48) KMT2ASLC6A2NPC1RAB9A
SCHEMBL21102467 0.70 SLC6A2 (0.44) KMT2ASLC6A2SLC6A4SLC6A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2060559-A1 Process for the preparation of enantiomerically pure 3-hydroxy-3-arylpropylamines and their optical stereoisomers Cadila Pharmaceuticals Limited (IN) 2009-05-20 EP disclosed
EP-2060559-A1 Process for the preparation of enantiomerically pure 3-hydroxy-3-arylpropylamines and their optical stereoisomers Cadila Pharmaceuticals Limited (IN) 2009-05-20 EP disclosed